Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two months

Guest Author 24/08/2016

Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two monthsJayne Lucke, La Trobe UniversityThe United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015.Australia hasn’t followed suit, though

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two months

Previous New funding for Australia’s HIV community

Next Community pharmacists need key HCH role: Guild

MENU

ajp.com.au

Previous New funding for Australia’s HIV community

Next Community pharmacists need key HCH role: Guild

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.